Charles River Laboratories
633 hedge funds and large institutions have $12.4B invested in Charles River Laboratories in 2023 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 204 increasing their positions, 258 reducing their positions, and 70 closing their positions.
167% more funds holding in top 10
Funds holding in top 10: 3 → 8 (+5)
34% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 70
22% more capital invested
Capital invested by funds: $10.1B → $12.4B (+$2.25B)
2% more funds holding
Funds holding: 621 → 633 (+12)
1.21% more ownership
Funds ownership: 101.05% → 102.25% (+1.2%)
21% less repeat investments, than reductions
Existing positions increased: 204 | Existing positions reduced: 258
32% less call options, than puts
Call options by funds: $54.7M | Put options by funds: $80.5M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$82.4M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$80.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$60.5M |
| 4 |
MG
Meritage Group
San Francisco,
California
|
+$53.4M |
| 5 |
SCA
Southpoint Capital Advisors
New York
|
+$39.3M |
Top Sellers
CRL Hedge Fund Activity: Q4 2023 in Review
633 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2023, worth a combined $12.4B — up 22% from $10.1B a quarter earlier.
Buyers outnumbered sellers: 94 funds opened new CRL positions and 70 closed out — a net gain of 24 holders — while 204 added to existing stakes and 258 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $82.4M. The largest seller was Fidelity Investments, cutting an estimated $103M.
- 633 institutional investors held Charles River Laboratories (CRL) as of Q4 2023, up from 621 in Q3 2023.
- Funds reported $12.4B of Charles River Laboratories stock for Q4 2023, up 22% quarter-over-quarter.
- 94 funds opened new Charles River Laboratories positions in Q4 2023 and 70 closed out, a net change of +24 holders.
- The largest Charles River Laboratories buyer in Q4 2023 was Morgan Stanley, an estimated $82.4M added.
- The largest Charles River Laboratories seller in Q4 2023 was Fidelity Investments, an estimated $103M sold.
Based on aggregated 13F filings for Q4 2023.